News and Announcements
Pre-IPO Opportunity: Leading experts in artificial intelligence and emotional analytics solutions – Invest alongside EverBlu Capital
- Published November 22, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Offer exclusively for 708 certified investors.
NVISO are leading experts in artificial intelligence, deep learning and emotion analytics solutions through deciphering human emotions, including tracking and deciphering micro-expressions and behaviours, by interpreting facial expressions and eye movements in real time.
NVISO is targeting an Initial Public Offering (IPO) on the Australian Securities Exchange (ASX) in early 2019.
NVISO’s key business is the further development and commercialisation of its technologies. The NVISO technologies use a combination of visual intelligence technologies such as image databases, deep learning algorithms, face recognition, facial analytics and emotion analytics which allows the Company to produce AI solutions and actionable data through its ability to measure instantaneous emotional reactions of consumers in digital and retail environments.
The NVISO SA technology has commercial application to financial service providers, market researchers, automotive manufacturers, healthcare providers and R&D product developers.
Investment Offering
NVISO is conducting a raise of up to A$750,000 via Pre-IPO Convertible Loan Offer.
EverBlu Capital and its principals have invested $180,000 in this offer and current Investors include four Sydney-based fund managers and selected HNWs.
NVISO Company Highlights
- Offering a commercially proven, unique solution to enterprise clientele, currently focussing on financial services
- Market Opportunity: Driven by Exploding Camera Usage (44 billion cameras by 2020)
- Revenue: From both AI enabled solutions offering and licencing the technology
- Huge multi-industry opportunity: Over next few years, including insurance and security
- Strong R&D Funding: Open innovation collaborative R&D, with leading companies including ARM
- Current clients include: Cetera Financial Group (USA), UBS (Switzerland) and PainChek (Australia)
- Re-signed their current biggest client, Cetera Financial, with new 3 year contract
- Strong revenue: Given the Cetera deal, revenues are on track to reach CHF 2.9m (~AUD $4m) this calendar year, with revenues locked in for next few years and strong growth forecasted 2019 and beyond
- Traction in Asia and Europe: Exhibited at multiple AI exhibitions in Asia and Europe, gaining traction and generating business throughout
- High calibre board of directors: Put in place a high calibre board of directors in preparation of the listing and future business growth
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
